Literature DB >> 22639424

Depressive symptoms in older people with metabolic syndrome: is there a relationship with inflammation?

Giovanni Viscogliosi1, Paola Andreozzi, Iulia Maria Chiriac, Elisa Cipriani, Adriana Servello, Benedetta Marigliano, Evaristo Ettorre, Vincenzo Marigliano.   

Abstract

OBJECTIVE: To investigate if there is a higher prevalence of depressive symptoms in older people with metabolic syndrome (MetS) compared with those without and whether dedpressive symptoms are independently associated to MetS and its single components and to the inflammatory markers.
METHODS: Physical parameters, standard blood analytes, high sensitivity C-reactive protein (hsCRP) and erythrocyte sedimentation rate (ESR) were assessed. Fifteen-item Geriatric Depression Scale and mini mental state examination (MMSE) were administered.
RESULTS: One hundred thirty-three subjects were enrolled. MetS patients (57) exhibited higher prevalence of depressive symptoms (p < 0.0001), worse cognitive function (p < 0.0001), and higher levels of ESR and hsCRP were higher (p < 0.0001). The univariate analysis showed a linear strong correlation of depressive symptoms (p < 0.0001) with the MMSE score (r = -0.422), body mass index (r = 0.414), MetS (r = 0.582), number of MetS components (r = 0.663), fasting blood glucose (r = 0.565), ESR (r = 0.565), hsCRP (r = 0.745), central obesity (r = 0.269; p = 0.002), and high-density lipoprotein cholesterol (r = -0.241; p = 0.005). However, the multivariate analysis showed that only age (B = -0.093; p = 0.032), MetS (B = 1.446; p = 0.025), fasting blood glucose (B = 0.039; p = 0.005), and hsCRP (B = 7.649; p < 0.0001) were independently associated with depressive symptoms.
CONCLUSIONS: MetS and inflammation are independently associated with depressive symptoms in older people. Inflammation may explain cognitive decline too. Further investigations are needed to better understand the direction of these associations and to determine whether these can be reversible.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22639424     DOI: 10.1002/gps.3817

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  15 in total

1.  Biochemical and Endocrine Parameters for the Discrimination and Calibration of Bipolar Disorder or Major Depressive Disorder.

Authors:  Yuncheng Zhu; Haifeng Ji; Zhiang Niu; Hongmei Liu; Xiaohui Wu; Lu Yang; Zuowei Wang; Jun Chen; Yiru Fang
Journal:  Front Psychiatry       Date:  2022-06-20       Impact factor: 5.435

2.  Multimorbidity in a Mexican Community: Secondary Analysis of Chronic Illness and Depression Outcomes.

Authors:  Kathleen O'Connor; Maricarmen Vizcaino; Jorge M Ibarra; Hector Balcazar; Eduardo Perez; Luis Flores; Robert L Anders
Journal:  Int J Nurs (N Y)       Date:  2015-06

Review 3.  Obesity and sex interact in the regulation of Alzheimer's disease.

Authors:  V Alexandra Moser; Christian J Pike
Journal:  Neurosci Biobehav Rev       Date:  2015-12-18       Impact factor: 8.989

4.  Association between C reactive protein level and depressive symptoms in an elderly Korean population: Korean Social Life, Health and Aging Project.

Authors:  Bo Mi Song; Ju-Mi Lee; Wungrak Choi; Yoosik Youm; Sang Hui Chu; Yeong-Ran Park; Hyeon Chang Kim
Journal:  BMJ Open       Date:  2015-02-23       Impact factor: 2.692

5.  Clinical, physical and lifestyle variables and relationship with cognition and mood in aging: a cross-sectional analysis of distinct educational groups.

Authors:  Nadine C Santos; Patrício S Costa; Pedro Cunha; Carlos Portugal-Nunes; Liliana Amorim; Jorge Cotter; João J Cerqueira; Joana A Palha; Nuno Sousa
Journal:  Front Aging Neurosci       Date:  2014-02-24       Impact factor: 5.750

Review 6.  Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments.

Authors:  Teresa C Castanho; Liliana Amorim; Joseph Zihl; Joana A Palha; Nuno Sousa; Nadine C Santos
Journal:  Front Aging Neurosci       Date:  2014-02-25       Impact factor: 5.750

7.  Deficiency of Complement Component C1Q Prevents Cerebrovascular Damage and White Matter Loss in a Mouse Model of Chronic Obesity.

Authors:  Leah C Graham; Heidi E Kocalis; Ileana Soto; Gareth R Howell
Journal:  eNeuro       Date:  2020-06-11

Review 8.  Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile.

Authors:  Brenda W J H Penninx; Yuri Milaneschi; Femke Lamers; Nicole Vogelzangs
Journal:  BMC Med       Date:  2013-05-15       Impact factor: 8.775

Review 9.  Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder.

Authors:  Juan Joseph Young; Tim Silber; Davide Bruno; Isaac Robert Galatzer-Levy; Nunzio Pomara; Charles Raymond Marmar
Journal:  Front Psychiatry       Date:  2016-04-25       Impact factor: 4.157

10.  Components of the metabolic syndrome and depressive symptoms in community-dwelling older people: the Bambuí Cohort Aging Study.

Authors:  Luiz Gustavo Ruas; Breno S Diniz; Josélia O Firmo; Sérgio V Peixoto; Juliana V Mambrini; Antônio Ignácio de Loyola-Filho; Maria Fernanda Lima-Costa; Érico Castro-Costa
Journal:  Braz J Psychiatry       Date:  2016-04-08       Impact factor: 2.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.